Emmes Publications | Emmes

Search

Show only items where

Author

Type

Term

Year

Keyword

Found 5 results

Author Title Type [ Year

]

Filters: Author is Dancey, Janet E [Clear All Filters]

2012

Busaidy, Naifa L, Azeez Farooki, Afshin Dowlati, John P Perentesis, Janet E Dancey, Laurence A Doyle, Joanna M Brell, and Lillian L Siu. 2012. “Management Of Metabolic Effects Associated With Anticancer Agents Targeting The Pi3K-Akt-Mtor Pathway.”. J Clin Oncol 30 (23). J Clin Oncol: 2919-28. doi:10.1200/JCO.2011.39.7356.

2010

Dancey, Janet E, Kevin K Dobbin, Susan Groshen, Milburn J Jessup, Andrew H Hruszkewycz, Maria Koehler, Ralph Parchment, et al.. 2010. “Guidelines For The Development And Incorporation Of Biomarker Studies In Early Clinical Trials Of Novel Agents.”. Clin Cancer Res 16 (6). Clin Cancer Res: 1745-55. doi:10.1158/1078-0432.CCR-09-2167.

2005

Dancey, Janet E, and Mason Schoenfeldt. 2005. “Clinical Trials Referral Resource. Current Clinical Trials Of Erlotinib.”. Oncology (Williston Park) 19 (9). Oncology (Williston Park): 1124, 1127-8, 1130 passim.

2003

Dancey, Janet E, and Mason Schoenfeldt. 2003. “Clinical Trials Referral Resource. Current Clinical Trials Of Agents Targeting Epidermal Growth Factor Receptor.”. Oncology (Williston Park) 17 (6). Oncology (Williston Park): 819, 826-30, 833-4 passim.

2002

Smith, Malcolm A, Janet E Dancey, Ewa Matczak, James A Zwiebel, Barry D Anderson, and Mason Schoenfeldt. 2002. “Clinical Trials Referral Resource. Current Clinical Trials Of Molecularly Targeted Agents In Children With Cancer, Part 2.”. Oncology (Williston Park) 16 (4). Oncology (Williston Park): 474, 479-80, 483-4 passim.